相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity
Meret Nora Gaugler et al.
ACTA NEUROPATHOLOGICA (2012)
Protein degradation pathways in Parkinson's disease: curse or blessing
Darius Ebrahimi-Fakhari et al.
ACTA NEUROPATHOLOGICA (2012)
Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants
Mauro Salvi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Suppression of -synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context
Vicente Sancenon et al.
HUMAN MOLECULAR GENETICS (2012)
Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4)
Onur Cizmecioglu et al.
JOURNAL OF CELL SCIENCE (2012)
Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease
Abid Oueslati et al.
JOURNAL OF NEUROSCIENCE (2012)
α-SYNUCLEIN PHOSPHORYLATION AND TRUNCATION ARE NORMAL EVENTS IN THE ADULT HUMAN BRAIN
G. Muntane et al.
NEUROSCIENCE (2012)
α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2
Shaoxiao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Increased α-synuclein phosphorylation and nitration in the aging primate substantia nigra
A. L. McCormack et al.
CELL DEATH & DISEASE (2012)
Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease
Jinxia Zhou et al.
ACTA NEUROPATHOLOGICA (2011)
被撤回的出版物: Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes (Retracted article. See vol. 295, pg. 13695, 2020)
Naomi P. Visanji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Authentically Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's Disease
Hiroyasu Sato et al.
JOURNAL OF NEUROSCIENCE (2011)
Characterization of Kinases Involved in the Phosphorylation of Aggregated α-Synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Requirement for Plk2 in Orchestrated Ras and Rap Signaling, Homeostatic Structural Plasticity, and Memory
Kea Joo Lee et al.
NEURON (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
Martial K. Mbefo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent Manner
Youhei Machiya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
Katerina E. Paleologou et al.
JOURNAL OF NEUROSCIENCE (2010)
Missing pieces in the Parkinson's disease puzzle
Jose A. Obeso et al.
NATURE MEDICINE (2010)
Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation
Danielle M. Evers et al.
NATURE NEUROSCIENCE (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
Polo-Like Kinase 2-Dependent Phosphorylation of NPM/B23 on Serine 4 Triggers Centriole Duplication
Annekatrin Krause et al.
PLOS ONE (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of α-synuclein in HEK293 cells
Masahiro Sakamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease
Samareh Azeredo da Silveira et al.
HUMAN MOLECULAR GENETICS (2009)
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Kelly J. Inglis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis
Kai-Yin Chau et al.
JOURNAL OF NEUROCHEMISTRY (2009)
α-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease
Nikolaus R. McFarland et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
Aaron D. Gitler et al.
NATURE GENETICS (2009)
Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease
Julien Dusonchet et al.
NEUROBIOLOGY OF DISEASE (2009)
NUCLEAR AND NEURITIC DISTRIBUTION OF SERINE-129 PHOSPHORYLATED α-SYNUCLEIN IN TRANSGENIC MICE
H. Schell et al.
NEUROSCIENCE (2009)
Plk2 regulated centriole duplication is dependent on its localization to the centrioles and a functional polo-box domain
Onur Cizmecioglu et al.
CELL CYCLE (2008)
Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein
Katerina E. Paleologou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Activity-induced polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity
Daniel P. Seeburg et al.
JOURNAL OF NEUROSCIENCE (2008)
Proteomics Analysis Identifies Phosphorylation-dependent α-Synuclein Protein Interactions
Melinda A. McFarland et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity
Daniel P. Seeburg et al.
NEURON (2008)
Pharmacological and functional comparison of the polo-like kinase family: Insight into inhibitor and substrate specificity
Eric F. Johnson et al.
BIOCHEMISTRY (2007)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms of Parkinson's disease linked to pathological α-synuclein:: New targets for drug discovery
Virginia M. -Y. Lee et al.
NEURON (2006)
Neural plasticity in the ageing brain
SN Burke et al.
NATURE REVIEWS NEUROSCIENCE (2006)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Regulation of cell cycle checkpoints by polo-like kinases
SQ Xie et al.
ONCOGENE (2005)
Polo-like kinases and oncogenesis
F Eckerdt et al.
ONCOGENE (2005)
Polo-like kinases in the nervous system
DP Seeburg et al.
ONCOGENE (2005)
Polo-like kinases (Plks) and cancer
N Takai et al.
ONCOGENE (2005)
Polo-like kinase-2 is required for centriole duplication in mammalian cells
S Warnke et al.
CURRENT BIOLOGY (2004)
Targeted protein degradation and synapse remodeling by an inducible protein kinase
DTS Pak et al.
SCIENCE (2003)
Phosphorylation of α-synuclein characteristic of synucleinopathy lesions is recapitulated in α-synuclein transgenic Drosophila
M Takahashi et al.
NEUROSCIENCE LETTERS (2003)
Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions
M Hasegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes
PJ Kahle et al.
EMBO REPORTS (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Synucleins are a novel class of substrates for G protein-coupled receptor kinases
AN Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
